PREDICTING HEART FAILURE FOLLOWING MYOCARDIAL INFARCTION BY PROTEASE AND PROTEASE INHIBITOR PROFILING.

摘要

Disclosed herein are methods of detecting or predicting diastolic heart failure in a subject, comprising identifying a profile of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) from a body fluid of the subject that is associated herein with the existence of likely development of left ventricular dilation (LVD).